Issue |
J Extra Corpor Technol
Volume 35, Number 1, March 2003
|
|
---|---|---|
Page(s) | 6 - 12 | |
DOI | https://doi.org/10.1051/ject/20033516 | |
Published online | 11 August 2023 |
Original Articles
Evaluation of Mimesys® Phosphorylcholine (PC)-Coated Oxygenators during Cardiopulmonary Bypass in Adults
1
Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia
2
University Hospital, Edmonton, Alberta
3
Cobe-Sorin Cardiovascular, Boulder, Colorado
* Address correspondence to: Gerard J. Myers, CCP, Cardiovascular Perfusion Services, Cardiac OR, NHI Campus, QEII Health Sciences Center, PO Box 9000, Halifax, Nova Scotia, Canada. B3K 6A3, E-mail: edit@ns.sympatico.ca
Received:
21
March
2002
Accepted:
December
2002
A new generation of coating extracorporeal circuitry with biocompatible polymers has entered the North American perfusion market. This new biomimetic coating process uses synthetic phosphorylcholine (PC) containing polymers to bond covalently to the surface of the Sorin Monolyth® oxygenator, under the brand name of Mimesys®. In part one of a three-part investigation, 160 Mimesys®-coated oxygenators were randomly evaluated against 36 uncoated oxygenators for blood flow, hemodynamic resistance, and pressure differentials. In part two, retrospective analysis of platelet data collected in this study was compared with platelet data collected from a previous investigation using uncoated Monolyth oxygenators with albumin and crystalloid perfusates. Part three examined the risk-adjusted oxygenators, compared with 71 case-matched patients treated with uncoated oxygenators. There was no difference found in the Mimesys-coated group, when compared to the control group, with regard to pressure differentials or hemodynamic resistance. However, we conclude that platelet protection with PC-coated Monolyth’s using crystalloid perfusates, was similar to platelet protection with albumin perfusates, and significantly better than uncoated Monolyths® using crystalloid perfusates.
Key words: phosphorylcholine / phospholipid / coated / oxygenators / biocompatible / platelets / zwitterionic / stroke / pressure excursion / adult / cardiopulmonary
© 2003 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.